Hydrolethalus Syndrome 1 (HYLS1) Peptide
-
- Target See all HYLS1 products
- HYLS1 (Hydrolethalus Syndrome 1 (HYLS1))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- YFEYKRDWDS IRLPGEDHRK ELRWGVREQM LCRAEPQSKP QHIYVPNNYL
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of HYLS1 antibody,
Alternative Names: HYLS1 control peptide, HYLS1 antibody Blocking Peptide, Anti-HYLS1 Blocking Peptide, Hydrolethalus Syndrome 1 Blocking Peptide, FLJ32915 Blocking Peptide, HLS Blocking Peptide - Purification
- Immunoaffinity chromatography
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- HYLS1 (Hydrolethalus Syndrome 1 (HYLS1))
- Synonyms
- HLS Peptide, 3010015K02Rik Peptide, HYLS1, centriolar and ciliogenesis associated Peptide, HYLS1 Peptide, Hyls1 Peptide
- Background
- This protein is a protein localized to the cytoplasm. Mutations in this protein are associated with hydrolethalus syndrome.
- Molecular Weight
- 34 kDa
-